Investigators analyzed the potential metabolic effects of lurasidone in a sample of patients with bipolar I depression.

Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.

There is enormous need for well-trained providers who are educated in treating opioid use disorder.

MDMA-assisted psychotherapy has demonstrated early success in PTSD in multiple phase 2 trials.

Researchers evaluated the efficacy and safety of trace amine associated receptor-1 agonist SEP-363856 in patients with schizophrenia.

If approved, HP-3070 would be the first transdermal antipsychotic available in the United States, and would provide a novel, safe, and efficacious treatment delivery system for adult patients with schizophrenia.

Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.

Over the course of 52 weeks, a combination of olanzapine and samidorphan was associated with minimal weight gain, tolerable adverse events, and durable antipsychotic effects in patients with schizophrenia.

Researchers sought to document and describe the contributions of certified PAs across practice areas in addressing mental health conditions.

Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.

Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.

In addition to improved symptoms, a delayed-release/extended-release methylphenidate was linked with improvements in early morning and late afternoon/evening functional impairment experienced by children with ADHD.

Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.

Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.

Higher rates of hopelessness, loneliness, anhedonia, social anxiety, and younger age were highly correlated with suicidal ideation in patients with major depressive disorder, based on a review of qualitative data.

Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.

Blood pressure should be assessed before treatment with esketamine nasal spray in patients with treatment-resistant depression.